Article

Specific ways brain SPECT imaging enhances clinical psychiatric practice.

Amen Clinics, Inc., Newport Beach, CA, USA.
Journal of psychoactive drugs (Impact Factor: 1.1). 04/2012; 44(2):96-106. DOI: 10.1080/02791072.2012.684615
Source: PubMed

ABSTRACT Our objective was to ascertain in a prospective case series how often brain single photon emission computed tomography (SPECT) neuroimaging adds relevant information for diagnosis and/or treatment beyond current standard assessment tools in complex psychiatric cases. Charts of 109 consecutively evaluated outpatients from four psychiatrics clinics that routinely utilize SPECT imaging for complex cases were analyzed in two stages. In stage one, psychiatrists reviewed detailed clinical histories, mental status exams, and the structured clinical interview for DSM-IV, but not the results of SPECT studies, assigned a diagnosis based on DSM-IV criteria, and then developed a comprehensive treatment plan. In stage two, evaluators were given access to the SPECT studies for each patient. The addition of SPECT modified the diagnosis or treatment plan in 78.9% (n=86; rated level 2 or 3 change) of cases. The most clinically significant changes were undetected brain trauma (22.9%), toxicity patterns (22.9%) and the need for a structural imaging study (9.2%). Specific functional abnormalities were seen as follows that potentially could impact treatment: temporal lobe dysfunction (66.1%) and prefrontal hypoperfusion (47.7%). SPECT has the potential to add clinically meaningful information to enhance patient care beyond current assessment tools in complex or treatment resistant cases.

Full-text

Available from: Daniel G. Amen, May 27, 2014
0 Followers
 · 
170 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: The utilization of various neuroimaging modalities to illuminate the structural and functional abnormalities detected in neuropsychiatric brain disorders has reached an unprecedented stage of evolvement in the medical community. Advances in structural and functional brain imaging technologies enable the medical community to discover the neurobiological basis of neurological illness in a very precise and dependable manner. Neuroimaging tools such as PET, SPECT and MRI have been better developed in order to further the neuroanatomical and neurophysiological basis of mental illnesses and cognitive disorders. With the advent of radiological innovation in neuroimaging, the focus in the medical community has shifted from the examination and study of single brain regions perhaps responsible for a specific psychiatric illness, to the critical examination of integrated brain systems which may be responsible for the phenotypic expressions of these illnesses. Imaging techniques have now made it quite clear that we must begin to investigate the neural networks involved in the pathophysiology of neuropsychiatric disorders. This paradigm shift, due to the innovations in brain imaging technologies, will likely facilitate the diagnostic reclassification of these complex heterogeneous disorders, enhance our understanding of genetic and environmental causes of the disorders, and improve our ability to treat these patients.
    06/2013; 3(2). DOI:10.4172/2161-0460.1000117
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Brain single-photon emission computed tomography (SPECT) scans indirectly show functional activity via measurement of regional cerebral blood flow. Thirty patients at a community-based psychiatric clinic underwent brain SPECT scans. Changes in scoring of before-treatment and after-treatment scans correlated well with changes in patient Global Assessment of Functioning (GAF) scores before treatment and after treatment. Patients were retrospectively matched with controls with similar diagnoses and pretreatment GAF scores, and those who underwent SPECT-guided treatment improved significantly more than the control patients.
    The Journal of neuropsychiatry and clinical neurosciences 11/2013; DOI:10.1176/appi.neuropsych.12100238 · 2.77 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The recent introduction of high-resolution molecular imaging technology is considered by many experts as a major breakthrough that will potentially lead to a revolutionary paradigm shift in health care and revolutionize clinical practice. This paper explores the challenges and strengths of the current major imaging modalities, as well as the biophysics engineering their repertoire of capabilities. Advancements in the mechanical aspects of both PET and SPECT imaging will advance molecular imaging diagnostic capabilities and have a direct impact on clinical medicine and biomedical research practice. A better understanding of the strengths and limitations of functional imaging modalities in the context of their particular hardware and software mechanics will shed light onto how we can advance their diagnostic capabilities on a biological level. Herein, this paper demonstrates the fundamental biomechanical differences between PET and SPECT imaging, and how these fundamental differences translate into clinically relevant data acquisition for brain disorders.
    07/2013; 4:157. DOI:10.4172/2155-9619.1000157